(AXS) AXIS Capital Holdings - Overview
Exchange: NYSE •
Country: Bermuda •
Currency: USD •
Type: Common Stock •
ISIN: BMG0692U1099
Stock:
Total Rating 55
Risk 82
Buy Signal 0.16
| Risk 5d forecast | |
|---|---|
| Volatility | 22.8% |
| Relative Tail Risk | 0.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | 4.63 |
| Character TTM | |
|---|---|
| Beta | 0.455 |
| Beta Downside | 0.944 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.73% |
| CAGR/Max DD | 1.41 |
EPS (Earnings per Share)
Revenue
Description: AXS AXIS Capital Holdings
AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products in Bermuda, the United States, and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers professional insurance products that cover directors' and officers' liability, errors and omissions, employment practices, fiduciary, crime, professional indemnity, medical malpractice, and other financial insurance related coverages for commercial enterprises, financial institutions, not-for-profit organizations, and other professional service providers; and property insurance products for commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism. This segment also provides marine and aviation insurance services for offshore energy, offshore renewable energy, cargo, liability, including kidnap and ransom, fine art, specie, and hull war, hull and liability, and specific war coverage for passenger airlines, cargo operations, general aviation operations, airports, aviation authorities, security firms, and product manufacturers; personal accident, travel insurance, specialty health products for employer and affinity groups, and pet insurance products; and liability, cyber, and credit and political risk insurance services. The Reinsurance segment offers agriculture, marine and aviation, catastrophe, accidental and health, credit and surety, motor, professional, travel, life, engineering, property, and liability reinsurance products. AXIS Capital Holdings Limited was founded in 2001 and is headquartered in Pembroke, Bermuda.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.72 > 1.0 |
| NWC/Revenue: 163.2% < 20% (prev 296.0%; Δ -132.8% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.69b > Net Income 1.01b |
| Net Debt (282.1m) to EBITDA (1.39b): 0.20 < 3 |
| Current Ratio: 3.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.8m) vs 12m ago -9.80% < -2% |
| Gross Margin: 36.07% > 18% (prev 0.30%; Δ 3577 % > 0.5%) |
| Asset Turnover: 19.85% > 50% (prev 18.51%; Δ 1.34% > 0%) |
| Interest Coverage Ratio: 19.33 > 6 (EBITDA TTM 1.39b / Interest Expense TTM 66.7m) |
Altman Z'' 3.56
| A: 0.33 (Total Current Assets 14.19b - Total Current Liabilities 3.69b) / Total Assets 32.32b |
| B: 0.25 (Retained Earnings 8.18b / Total Assets 32.32b) |
| C: 0.04 (EBIT TTM 1.29b / Avg Total Assets 32.42b) |
| D: 0.32 (Book Value of Equity 8.21b / Total Liabilities 25.97b) |
| Altman-Z'' Score: 3.56 = A |
Beneish M -2.84
| DSRI: 1.13 (Receivables 12.87b/10.67b, Revenue 6.44b/6.02b) |
| GMI: 0.82 (GM 36.07% / 29.74%) |
| AQI: 1.41 (AQ_t 0.56 / AQ_t-1 0.40) |
| SGI: 1.07 (Revenue 6.44b / 6.02b) |
| TATA: -0.05 (NI 1.01b - CFO 2.69b) / TA 32.32b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of AXS shares?
As of March 01, 2026, the stock is trading at USD 105.72 with a total of 321,644 shares traded.
Over the past week, the price has changed by +0.68%, over one month by +3.13%, over three months by +3.82% and over the past year by +11.73%.
Over the past week, the price has changed by +0.68%, over one month by +3.13%, over three months by +3.82% and over the past year by +11.73%.
Is AXS a buy, sell or hold?
AXIS Capital Holdings has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy AXS.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 123.6 | 17% |
| Analysts Target Price | 123.6 | 17% |
AXS Fundamental Data Overview February 28, 2026
P/E Trailing = 8.4704
P/E Forward = 7.6746
P/S = 1.2459
P/B = 1.3879
P/EG = -10.28
Revenue TTM = 6.44b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 109.0m USD (from shortTermDebt, two quarters ago)
Debt = 1.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 282.1m USD (from netDebt column, last quarter)
Enterprise Value = 8.46b USD (8.18b + Debt 1.60b - CCE 1.32b)
Interest Coverage Ratio = 19.33 (Ebit TTM 1.29b / Interest Expense TTM 66.7m)
EV/FCF = 3.13x (Enterprise Value 8.46b / FCF TTM 2.70b)
FCF Yield = 31.96% (FCF TTM 2.70b / Enterprise Value 8.46b)
FCF Margin = 42.01% (FCF TTM 2.70b / Revenue TTM 6.44b)
Net Margin = 15.68% (Net Income TTM 1.01b / Revenue TTM 6.44b)
Gross Margin = 36.07% ((Revenue TTM 6.44b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 33.44%)
Tobins Q-Ratio = 0.26 (Enterprise Value 8.46b / Total Assets 32.32b)
Interest Expense / Debt = 1.05% (Interest Expense 16.8m / Debt 1.60b)
Taxrate = 13.70% (46.0m / 335.6m)
NOPAT = 1.11b (EBIT 1.29b * (1 - 13.70%))
Current Ratio = 3.85 (Total Current Assets 14.19b / Total Current Liabilities 3.69b)
Debt / Equity = 0.25 (Debt 1.60b / totalStockholderEquity, last quarter 6.36b)
Debt / EBITDA = 0.20 (Net Debt 282.1m / EBITDA 1.39b)
Debt / FCF = 0.10 (Net Debt 282.1m / FCF TTM 2.70b)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 1.01b / Total Assets 32.32b)
RoE = 16.27% (Net Income TTM 1.01b / Total Stockholder Equity 6.20b)
RoCE = 17.14% (EBIT 1.29b / Capital Employed (Equity 6.20b + L.T.Debt 1.32b))
RoIC = 15.93% (NOPAT 1.11b / Invested Capital 6.98b)
WACC = 6.49% (E(8.18b)/V(9.78b) * Re(7.59%) + D(1.60b)/V(9.78b) * Rd(1.05%) * (1-Tc(0.14)))
Discount Rate = 7.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.08%
[DCF] Terminal Value 86.33% ; FCFF base≈2.36b ; Y1≈2.91b ; Y5≈4.95b
[DCF] Fair Price = 1552 (EV 119.86b - Net Debt 282.1m = Equity 119.58b / Shares 77.0m; r=6.49% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 45.73 | EPS CAGR: 12.49% | SUE: 0.52 | # QB: 0
Revenue Correlation: 92.45 | Revenue CAGR: 7.86% | SUE: 2.12 | # QB: 2
EPS next Quarter (2026-03-31): EPS=3.45 | Chg7d=+0.000 | Chg30d=+0.034 | Revisions Net=+4 | Analysts=11
EPS current Year (2026-12-31): EPS=13.32 | Chg7d=+0.000 | Chg30d=+0.084 | Revisions Net=+3 | Growth EPS=+3.1% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=14.51 | Chg7d=+0.000 | Chg30d=+0.067 | Revisions Net=+6 | Growth EPS=+9.0% | Growth Revenue=+6.5%
[Analyst] Revisions Ratio: +0.40 (7 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.9% (Discount Rate 7.9% - Earnings Yield 11.8%)
[Growth] Growth Spread = +7.3% (Analyst 3.5% - Implied -3.9%)
P/E Forward = 7.6746
P/S = 1.2459
P/B = 1.3879
P/EG = -10.28
Revenue TTM = 6.44b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 109.0m USD (from shortTermDebt, two quarters ago)
Debt = 1.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 282.1m USD (from netDebt column, last quarter)
Enterprise Value = 8.46b USD (8.18b + Debt 1.60b - CCE 1.32b)
Interest Coverage Ratio = 19.33 (Ebit TTM 1.29b / Interest Expense TTM 66.7m)
EV/FCF = 3.13x (Enterprise Value 8.46b / FCF TTM 2.70b)
FCF Yield = 31.96% (FCF TTM 2.70b / Enterprise Value 8.46b)
FCF Margin = 42.01% (FCF TTM 2.70b / Revenue TTM 6.44b)
Net Margin = 15.68% (Net Income TTM 1.01b / Revenue TTM 6.44b)
Gross Margin = 36.07% ((Revenue TTM 6.44b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 33.44%)
Tobins Q-Ratio = 0.26 (Enterprise Value 8.46b / Total Assets 32.32b)
Interest Expense / Debt = 1.05% (Interest Expense 16.8m / Debt 1.60b)
Taxrate = 13.70% (46.0m / 335.6m)
NOPAT = 1.11b (EBIT 1.29b * (1 - 13.70%))
Current Ratio = 3.85 (Total Current Assets 14.19b / Total Current Liabilities 3.69b)
Debt / Equity = 0.25 (Debt 1.60b / totalStockholderEquity, last quarter 6.36b)
Debt / EBITDA = 0.20 (Net Debt 282.1m / EBITDA 1.39b)
Debt / FCF = 0.10 (Net Debt 282.1m / FCF TTM 2.70b)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 1.01b / Total Assets 32.32b)
RoE = 16.27% (Net Income TTM 1.01b / Total Stockholder Equity 6.20b)
RoCE = 17.14% (EBIT 1.29b / Capital Employed (Equity 6.20b + L.T.Debt 1.32b))
RoIC = 15.93% (NOPAT 1.11b / Invested Capital 6.98b)
WACC = 6.49% (E(8.18b)/V(9.78b) * Re(7.59%) + D(1.60b)/V(9.78b) * Rd(1.05%) * (1-Tc(0.14)))
Discount Rate = 7.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.08%
[DCF] Terminal Value 86.33% ; FCFF base≈2.36b ; Y1≈2.91b ; Y5≈4.95b
[DCF] Fair Price = 1552 (EV 119.86b - Net Debt 282.1m = Equity 119.58b / Shares 77.0m; r=6.49% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 45.73 | EPS CAGR: 12.49% | SUE: 0.52 | # QB: 0
Revenue Correlation: 92.45 | Revenue CAGR: 7.86% | SUE: 2.12 | # QB: 2
EPS next Quarter (2026-03-31): EPS=3.45 | Chg7d=+0.000 | Chg30d=+0.034 | Revisions Net=+4 | Analysts=11
EPS current Year (2026-12-31): EPS=13.32 | Chg7d=+0.000 | Chg30d=+0.084 | Revisions Net=+3 | Growth EPS=+3.1% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=14.51 | Chg7d=+0.000 | Chg30d=+0.067 | Revisions Net=+6 | Growth EPS=+9.0% | Growth Revenue=+6.5%
[Analyst] Revisions Ratio: +0.40 (7 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.9% (Discount Rate 7.9% - Earnings Yield 11.8%)
[Growth] Growth Spread = +7.3% (Analyst 3.5% - Implied -3.9%)